Latest filing published 26 Mar 2025 for Mind Medicine (MindMed) Inc., €15k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Carrie Liao: trading record in brief
This profile gathers the share dealings of Carrie Liao in Definium Therapeutics, Inc., where the filings describe the role as senior executive. The record holds 7 filings, for trades running from 10 February 2022 to 25 March 2025.
No open-market purchase appears, only 3 sales worth €44k. Other entries cover 4 share grants. 2025 to date brings no purchases and 1 sale.
The latest filing, published on 26 March 2025, reports an open-market sale of €15k in Definium Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carrie Liao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,347 shares@ US$6.7433.6% of flowCommon SharesSEC:0000950170-25-045393:0
- 50,000 shares0Common SharesSEC:0000950170-25-038796:0
- 2,273 shares@ US$7.4337.3% of flowCommon SharesSEC:0001104659-24-132166:0
- 2,352 shares@ US$5.9829.0% of flowCommon SharesSEC:0000950170-24-109450:0
- 75,000 shares0Common SharesSEC:0001209191-23-025474:0
- 75,000 shares0Common SharesSEC:0001209191-23-019895:0
- 403,430 shares0Subordinate Voting SharesSEC:0001209191-22-018614:0
7 of 7 declarations
